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Abstract: Uniform Nd3+-doped LuVO4 nanophosphors have been synthesized for the first time in
literature by using a poliol-based method at 120 ◦C from Nd3+ and vanadate precursors. After optimizing
the Nd doping level, these phosphors present intense luminescence in the near-infrared biological
windows. The X-ray attenuation capacity of the optimum nanophosphor has been found to be higher
than that of a commercial X-ray computed tomography contrast agent. After surface coating with
polyacrylic acid, such nanoparticles present high colloidal stability in physiological pH medium and high
cell viability. Because of these properties, the developed Nd3+-doped LuVO4 nanoparticles have potential
applications as a bimodal probe for NIR luminescent bioimaging and X-ray computed tomography.
Keywords: nanoparticles; LuVO4; neodymium; polyacrilic acid; NIR luminescence; X-ray computed
tomography
1. Introduction
Among the most interesting techniques for medical diagnosis are luminescent imaging (LI),
magnetic resonance imaging (MRI), and X-ray computed tomography (CT) [1]. In both cases, the use
of external probes as contrast agents is usually required. Several compounds have been assayed for
such a purpose, among which rare earth vanadate (REVO4)-based nanophosphors composed by a
REVO4 matrix in which different luminescent lanthanide (Ln) cations are introduced as dopants, have
been recently the focus of much attention. In particular, Ln-doped REVO4 (RE = Y, La, Gd; Ln = Eu, Tb,
Dy, Sm, Nd, Yb), have been proposed as excellent probes for luminescent “in vitro” bioimaging and
biosensing [2–10], owing to their intense luminescence on excitation by UV light through an energy
transfer process from the vanadate matrix to the Ln3+ cations [11]. However, the need for UV excitation
is a drawback for in vivo bioapplications because of the potential damage that such radiation may
cause to living organisms. It has been shown that for such applications, the use of doping Ln3+ cations
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whose luminescent properties are located within the biological windows in the near-infrared (NIR)
region would be more appropriate, as it is the case of Nd3+ [12].
REVO4-based multifunctional probes useful for more than one imaging technique have been
also reported. For example, Ln-doped GdVO4 (Ln = Eu, Dy) nanoparticles have been shown to be
promising candidates as both luminescent and MRI probes due to the magnetic properties of the Gd3+
cations [2–5]. In addition, because the atomic number of Ln is high, the X-ray attenuation capability
of these elements is also high [13], and consequently, Ln-based nanoparticles can be also used as
contrast agents for CT. For that reason, Lu3+-based compounds are the most advantageous probes for
this application. However, in the case of LnVO4 compounds, this additional functionality has been
only studied for the of case Ln-doped Y(Gd)VO4 (Ln = Eu, Dy, Sm) nanoparticles [14]. It should be
also noticed that no reports on the development of luminescent Nd:LuVO4-based bioprobes could be
found in the literature either. The lack of antecedents regarding to the potential use of this material for
bioimaging purposes might be due to the scarce availability of synthesis methods yielding Ln-doped
LuVO4 particles with appropriated characteristics for such uses, namely, uniformity in size and
shape, particle size lower than 100 nm, low cytotoxicity, and high colloidal stability in physiological
media [15,16].
In this paper, we report on a procedure for the synthesis, for the first time in the literature, of uniform
Nd3+-doped LuVO4 nanophosphors with nearly equiaxial shape by homogeneous precipitation at
120 ◦C from ethylene glycol (EG)/water solutions containing Ln3+ nitrates and sodium orthovanadate.
The effects of the amount of Nd3+ incorporated into the LuVO4 matrix on the luminescence of the
obtained nanoparticles have been studied aiming to establish the optimum Nd3+ content. The X-ray
attenuation capacity of the optimized phosphor has been also evaluated in comparison with that of
Iohexol, one of the CT contrast agents most used in clinics. To achieve the colloidal stability criteria in
physiological pH conditions, the optimum sample has been surface coated with polyacrylic acid (PAA)
molecules and the cell viability of such functionalized samples has been also analyzed. This study
demonstrates that the developed Nd3+:LuVO4 nanophosphors are promising candidates for their use
as a bimodal probe for in vivo luminescent bioimaging and X-ray computed tomography.
2. Materials and Methods
2.1. Materials
Lutetium (III) nitrate hydrate (Lu(NO3)3·xH2O, Sigma-Aldrich, 99.9%, St. Louis, MO, USA),
neodymium (III) nitrate hexahydrate (Nd(NO3)3·6H2O, Sigma-Aldrich, 99.9%, St. Louis, MO, USA),
sodium orthovanadate (Na3VO4, Sigma-Aldrich, 99.9%, St. Louis, MO, USA), ethylene glycol (EG,
Sigma-Aldrich, 99.9%, St. Louis, MO, USA), polyacrylic acid (PAA, average Mw~1800, Sigma-Aldrich,
St. Louis, MO, USA), 2-morpholinoethanesulfonic acid (MES, Sigma-Aldrich, 99%, St. Louis, MO, USA),
and Iohexol (Sigma-Aldrich, analytical standard, ≥95%, St. Louis, MO, USA) were used as received.
2.2. Synthesis of LuVO4 Nanoparticles
Nd-doped LuVO4 nanoparticles having different Nd contents (Nd/(Nd + Lu) mol ratio = 0, 0.2,
0.5, 1.0, 1.5, 2.0) were synthesized by homogeneous precipitation according to a procedure previously
developed by us for the preparation of GdVO4 nanoparticles [2], which was adapted by introducing
the needed modifications in order to produce nanoparticles of the desired compound with narrow size
distribution. Specifically, for a given doping level, the required amounts of the lanthanide precursors
(Lu(NO3)3 and Nd(NO3)3, total Ln concentration = 0.04 moldm−3), and Na3VO4 (0.04 mol dm−3) were
separately dissolved in Milli-Q water (0.75 cm3) under magnetic stirring. EG (1.75 cm3) was then
added to each of these solutions. After homogenization, they were mixed under vigorous stirring.
The resulting mixture (total volume = 5 cm3) introduced in a test tube, which was tightly closed, was
aged for 20 h in an oven at constant temperature (120 ◦C). The obtained dispersions were allowed to
cool to room temperature. The precipitates were purified by centrifugation and redispersion, twice in
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ethanol and once in distilled water. The as-prepared particles were stored dispersed in Milli-Q water
and dried at room temperature when required.
2.3. PAA Functionalization of LuVO4 Nanoparticles
PAA (2 mg cm−3) was dissolved in Milli-Q water containing 0.5 mg cm−3 of Nd:LuVO4
nanoparticles. After adjusting the pH of this dispersion to 10 by adding a few droplets of a NaOH
solution, it was maintained for 1 h at −25 ◦C under magnetic stirring. Afterward, the supernatants
were removed by centrifugation and the surface-modified nanoparticles were washed several times
with Milli-Q water and finally dispersed in Milli-Q water.
2.4. Characterization
Transmission electron micrographs (TEM) were taken in a Philips 200CM microscope
(ThermoFisher Scientific, Hillsboro, OR, USA). Particle size distributions were estimated from the TEM
pictures by counting hundreds of particles.
X-ray diffraction (XRD) patterns were recorded in a Panalytical X′Pert Pro diffractometer (Malvern
Panalytical, Cambridge, UK) equipped with an X-Celerator detector. Unit cell constants were calculated
by Rietveld refinement of the XRD patterns (registered with a 0.02◦ 2θ step and an accumulation time
of 1000 s) using the X′Pert High Score Plus software.
The infrared spectra (FTIR) of the samples diluted in KBr were measured in a JASCO FT/IR-6200
apparatus (Jasco Europe SRL, Cremella, Italy).
Thermogravimetric analyses (TGA) were conducted in air atmosphere employing a heating rate
of 10 ◦C min−1 in a Q600 TA instrument (TA instrument, New Castle, DE, USA).
Excitation and emission spectra of the samples in powdered form were obtained using a tunable
Ti:Sapphire laser as excitation source. To obtain comparative data, we employed the same amount
of sample, which was placed in a hole (3 mm diameter) practiced in an aluminum foil, which was
sandwiched between two microscope slides. Lifetime measurements were carried out by exciting
the samples at 532 nm with the second harmonic of a pulsed Nd:YAG laser (pulse width, 10 ns and
repetition rate, 10 Hz) and recording the luminescence decay at λexc = 1344 nm (4F3/2→ 4I13/2 transition)
using a Tektronix DPO4104B-L digital oscilloscope.
CT measurements were acquired with a NanoSPECT/CT® apparatus (Mediso, Budapest, Hungary).
For such a purpose, different amounts of the sample were dispersed in Milli-Q and the dispersion was
homogenized in a vortex device for 2 min before measurements. Afterward, 200 µL of each dispersion
was introduced in a multiwell microplate, along with a Milli-Q water aliquot used for calibration.
The acquisition parameters were: 106 mA current for a voltage of 65 kV, exposure time per projection
of 1500 ms, 360 projections per rotation, and total acquisition time of 18 min. The image length was
6 cm, with a pitch of 1. The image was reconstructed with Vivoquant image processing software
(Invicro, London, UK), with the exact cone-beam filtered back-projection algorithm and the Shepp
Logan 98% filter. The resulting image pixel size was uniform in three dimensions at 0.2 mm. Images
were analyzed with PMOD 3.8 software (PMOD Technologies LLC, Zürich, Switzerland). Spherical
volumes of interest (VOIs) of a 2 mm radius were made within each sample to calculate the X-ray
attenuation (in Hounsfield Units, HU) for each concentration. Average values of Milli-Q water and
dispersions were used to calculate HU values in the images, with attenuation being 0 HU for water
and −1000 HU for air.
The colloidal stability of the dispersions containing the nanophosphors (0.1 mg cm−3) in 50 mM
MES solution at pH = 6.5 was evaluated by measuring the hydrodynamic diameter (dh) by dynamic
light scattering (DLS) using a Zetasizer NanoZS90, Malvern instrument.
To analyze cytotoxicity, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
colorimetric assay [17] and Vero cells (kidney epithelial cells from African green monkey) were used.
The cells, purchased from the American Type Culture Collection (ATCC: CCL-81), were cultured in a
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5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 2 mM glutamine, and 100 U cm−3 penicillin/streptomycin at 37 ◦C.
For the MTT analysis, 5000 cells were first seeded in each well of 96-well plates and grown for 24 h.
Then, the medium was substituted with fresh medium containing variable amounts of nanoparticles.
After further cultivation for 24 h, 20 µL of MTT dye solution (5 mg cm−3 in PBS) was added to each
well. After 3 h of incubation at 37 ◦C and 5% CO2, the medium was removed, the cells were washed
with fresh medium, the plate was centrifuged at 2500 rpm for 30 min, the supernatant was discarded,
and formazan crystals were dissolved in 100 µL of DMSO. The absorbance of each well was read on
a microplate reader (Multiskan GO, Thermo Scientific, Waltham, MA, USA) at 570 nm. The relative
cell viability (%) related to control wells containing cells without nanoparticles was calculated as
[A]test/[A]control × 100.
3. Results
3.1. Samples Preparation and Characterization
The aging at 120 ◦C for 20 h of Ln nitrate (Lu(NO3)3 + Nd(NO3)3 = 0.04 mol dm−3 and Nd/(Nd
+ Lu) mol ratio from 0.2% to 2%) and sodium orthovanadate (0.04 mol dm−3) solutions in EG/water
(3.5/1.5 by volume) yielded almost equiaxed nanoparticles as those illustrated in Figure 1, in which the
undoped sample and that with the highest doping level are shown.
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Figure 1. TEM images of the particles synthesized by precipitating solutions in EG/H2O (3.5/1.5)
containing: (top) Na3VO4 (0.04 m l dm−3) and Lu(NO3)3 = 0.04 mol dm−3; (down) under the same
conditions but in the presence of 2% Nd (Nd/(Nd + Lu) mol ratio). In both cases, the aging temperature
was set at 120 ◦C and aging time was 20 h.
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The particle size, as measured from the TEM micrographs, was found to be ~70 nm for all samples,
irrespective of the doping level (Table 1).
Table 1. Mean size, unit cell parameters, cell volume, and crystallite size of the particles obtained by
aging at 120 ◦C for 20 h. EG/H2O solutions containing Lu(NO3)3, Nd(NO3)3, (Nd(NO3)3 + Lu(NO3)3
= 0.04 mol dm−3, and variable Nd/(Nd + Lu mol ratio) and sodium orthovanadate (0.04 mol dm−3)
in EG/H2O medium (ratio by volume = 3.5/1.5). Standard deviations for particle size and unit cell
parameters errors are included in parentheses.
Nd/(Nd + Lu) Mean Size a = b c Cell Volume
(% Nominal) (nm) (Å) (Å) (Å3)
0 60 (14) 7.0330(9) 6.2180(1) 307.58
0.2 73 (11) 7.0305(7) 6.2274(7) 307.80
0.5 70 (12) 7.0332(7) 6.2280(7) 308.07
1.0 75 (9) 7.0341(6) 6.2296(6) 308.20
1.5 77 (13) 7.0352(5) 6.2294(5) 308.31
2.0 75 (10) 7.0367(6) 6.2321(6) 308.58
According to XRD, the obtained nanoparticles consisted of tetragonal LuVO4 (PDF 1-72-270, ICDD
2016), irrespective of the Nd content (Figure 2). The successful incorporation of Nd3+ into the LuVO4
lattice was assessed by the evaluation of the unit cell constants of the samples. As observed in Table 1,
the increase of the Nd content gave rise to a progressive unit cell expansion, which manifests that the
Lu3+ cations have been substituted by Nd3+ in the LuVO4 structure since the ionic radius in of Nd3+
(1.109 Å) is greater than that of Lu3+ (0.977 Å), both in eight-fold coordination [18].
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3.2. NIR Luminescence
The number, position, and relative intensity of the excitation bands registered for the emission
appearing at 1066 nm for the Nd:LuVO4 nanoparticles were similar, irrespective of the Nd content.
As an illustrative example, the spectrum of the sample doped with a 0.2% molar of Nd3+ is shown in
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Figure 3. As expected, this spectrum shows three groups of bands in the 730–790 nm, 790–850 nm,
and 870–930 nm regions, associated to the 4I9/2 → 4S3/2:4F7/2, 4I9/2 → 2H9/2:4F5/2, and 4I9/2 → 4F3/2 f-f
electronic transitions of the Nd3+ ions, respectively [7].
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The e ission spectra of the Lu 4 nanoparticles containing different a ounts of Nd3+ obtained
upon excitation through the most intense excitation band (λex = 810 nm) are presented in Figure 4 (top).
The emission bands characteristic of the 4F3/2→ 4IJ (J = 9/2, 11/2 and 13/2) electronic transitions of Nd3+
were detected in all cases [7], whose intensity varies with the doping level. Thus, when plotting the
integrated area of the emissions vs. the Nd content (Figure 4 (down)), it was clearly observed that the
rise of the Nd3+ doping level up to 1.5% produced a progressive increase of the emission intensity,
which must be attributed the increase of the number of emission centers. However, above such doping
levels (2%), the emission intensity decreased, suggesting the presence of concentration quenching.
This k own effect was further confirmed by determining the luminescence lifetime of the samples.
The decay curves corresponding to the 4F3/2→ 4I13/2 Nd3+ transition (1344 nm) of the Nd:LuVO4
samples are presented in Figure 5 in a semi-logarithmic plot. As it can be observed, after an initial rise,
the luminescence temporal evolutio decays following a single expone tial dependence:
I(t) = I0 exp(−t/τ) (1)
where I(t) is the luminescence intensity, I0 is the initial intensity, t is the time after excitation, and τ is
the decay time. Dashed lines in Figure 5 correspond to least squares fitting.
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The corresponding decay time values obtained from this fitting are also included in Figure 5, and
their evolution with Nd3+ concentration is plotted in Figure 6. As observed, the decay time decreases
monotonously with Nd3+ content, indicating the occurrence of concentration quenching processes,
which become more evident at doping levels ≥1% Nd. This implies a reduction in the luminescence
efficiency that counterbalances the rise in the number of emitting centers as concentration increases.
According to the results obtained under CW excitation (Figure 5), the best compromise seems to
happen for the sample having a 1.5% Nd, which can be considered, from a practical point of view, as
the optimum nanophosphor for bioimaging owing to its highest emission intensity.
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3.3. X-Ray Attenuation
The X-ray attenuation properties of the optimum nanophosphor (Nd (1.5%):LuVO4) and those
of Iohexol, which is one of the most commonly used CT contrast agents in clinics, were measured in
aqueous suspensions.
The obtained X-ray attenuation phantom images are shown in Figure 7 (top), where it can be
clearly observed that the contrast produced by increasing the nanophosphor’s concentration in the
suspensions is higher than that corresponding to Iohexol, suggesting better performance of our
nanoparticles as a CT contrast agent. This finding was further corroborated by the X-ray attenuation
values, in Hounsfield units (HU), which were estimated from the phantom images, and plotted in
Figure 7 (bottom) as a function of the nanophosphor’s concentration. This figure reveals an increase
of the HU values by increasing the concentration of the suspensions following a straight line whose
slope is higher for our system (27.3 HU/mg cm−3) than for Iohexol (15.3 HU/mg cm−3). This behavior
is not surprising given the expected increase of the X-ray attenuation coefficient when the average
atomic number of the elements constituting the probe increases [13]. The excellent X-ray attenuation
properties of our nanophosphors indicate that they can be used not only as a probe for NIR imaging
but also as a CT contrast agent.
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3.4. Colloidal Stability and PAA Surface Modification
The colloidal stability of our optimum bifunctional probe (Nd (1.5%):LuVO4) was evaluated
through DLS measurements conducted in freshly prepared suspensions containing our nanoparticles
in MES buffer at physiological pH (MES 50 mM at pH = 6.5).
It was found that the hydrodynamic diameter (dh) obtained from the DLS curve (Figure 8) was
much higher (1280 nm) than the mean particle size resulting from the analysis of the TEM pictures
(77 nm) indicating that this sample does not meet the stability criterion established for the use for
in vivo applications. To overcome this limitation, a surface modification approach, consisting of a
coating process of the nanoparticles with PAA polymer, was undertaken. After such a process, a
surface charge reversal was detected. Thus, the zeta potential value changed from +25 mV to −45 mV
after functionalization, which suggests the presence of PAA molecules with ionized carboxylate groups
on the particle surface. These species could be identified in the FTIR spectra of the functionalized
sample. Thus, the spectrum of the pristine sample (Figure 9, top) only displayed the absorption features
associated with the vanadate vibrational modes (<1000 cm−1) [7], adsorbed water (3400 and 1625 cm−1),
and a very weak band at 1370 cm−1 probably due to residual EG molecules [19]. However, additional
weaker features in the 1600–1400 cm−1 region were detected in the spectrum of the functionalized
nanoparticles, which can be attributed to the asymmetric (1545 cm−1) and symmetric (1400 cm−1)
stretching vibrations of the carboxylate groups of the PAA molecules [7]. These results confirm that
our functionalization procedure was successful.
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The amount of PAA polymer deposited on the nanoparticle surface could be quantified according
to the TGA curves presented in Figure 9 (bottom). As observed, in the curve corresponding to the
original sample a first weight loss (~4%) was detected in the 25–300 ◦C range due to the removal of
adsorbed water. The smaller loss (1.5%) that occurred at higher temperatures (300–700 ◦C) might be a
consequence of the decomposition of the residual EG molecules. The functionalized sample presented
an additional weight loss (2%) between 300 and 500 ◦C, which must be due to the decomposition of
PAA entities.
The PAA coating gave rise to an improvement in the colloidal stability of the nanophosphor. Thus,
the value of dh obtained in MES media after functionalization (Figure 8) was closer (90 nm) to the
mean particle size (77 nm), clearly indicating the absence of significant aggregation, as required for the
intended biomedical application of the developed probe.
3.5. Biocompatibility
Cell viability analyses were performed for the optimum nanophosphor using the MTT assay [17]
with Vero cells. The metabolic activity of the cells measured for different nanoparticles concentrations
after 24 h culture is shown in Figure 10, in which it can be observed that cell survival remained above
65% for nanoparticle contents in the suspensions up to 0.3 mg cm−3.
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4. Conclusions
The aging at 120 ◦C for 20 h of solutions containing precise amounts of Lu(NO3)3, Nd(NO3)3,
(Lu(NO3)3 + Nd(NO3)3 = 0.04 mol dm−3 and variable Nd/(Nd + Lu mol ratio), and sodium
orthovanadate (0.04 mol dm−3) in EG/H2O medium (3.5/1.5 ratio, by volume) yields Nd3+-doped
LuVO4 nanoparticles with almost equiaxed shape and narrow size distribution (~70 nm). These
particles crystallize into the tetragonal phase and show polycrystalline character. Irrespective of the
Nd content (from 0.2% to 2%), NIR emissions in the 850–1400 nm region were detected for all samples
upon excitation at 811 nm. The most intense emissions corresponded to the particles doped with 1.5
mol% Nd3+, for which they were considered as the optimum nanophosphors for bioimaging. The X-ray
attenuation properties of this nanophosphor were higher than that of Iohexol, a commercial X-ray
computed tomography contrast agent. After surface coating with polyacrylic acid molecules, this
probe showed high colloidal stability in aqueous suspensions at physiological pH and low cytotoxicity.
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Because of these properties, the Nd-doped LuVO4 nanoparticles functionalized with polyacrylic acid
can be considered as promising candidates for their use as bimodal probes for NIR luminescent
bioimaging and X-ray computed tomography.
Author Contributions: N.O.N. synthesized and characterized the samples; F.C. and E.C. recorded and analyzed
the luminescence data; B.M.-G. and J.M.d.l.F. analyzed cytotoxicity; A.C. and M.B. recorded and analyzed the
X-ray attenuation measurements; M.O. conceptualized the study, supervised the work, and wrote the manuscript.
All authors have read and agree to the published version of the manuscript.
Funding: This work has been supported by the Spanish Ministry of Science, Innovation and Universities
(MCIU/AEI/FEDER) under grant RTI2018-094426-B-I00, and Ministerio de Economía y Competitividad (MINECO)
under project MAT2016-75716-C2-2-R.
Acknowledgments: Support by Siemens Healthcare S.L.U is acknowledged. Authors also acknowledge CNA
for the use of the ICTS NanoCT facilities and support from DGA and Fondos Feder for funding Bionanosurf
(E15_17R) research group B. Martin acknowledges DGA for a predoctoral grant.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Leary, J.F.; Key, J. Nanoparticles for multimodal in vivo imaging in nanomedicine. Int. J. Nanomed. 2014, 9,
711–726. [CrossRef] [PubMed]
2. Nuñez, N.O.; Rivera, S.; Alcántara, D.; De La Fuente, J.M.; García-Sevillano, J.; Ocaña, M. Surface modified
Eu:GdVO4 nanocrystals for optical and MRI imaging. Dalton Trans. 2013, 42, 10725. [CrossRef] [PubMed]
3. Dong, K.; Ju, E.; Liu, J.; Han, X.; Ren, J.; Qu, X. Ultrasmall biomolecule-anchored hybrid GdVO4
nanophosphors as a metabolizable multimodal bioimaging contrast agent. Nanoscale 2014, 6, 12042–12049.
[CrossRef] [PubMed]
4. Abdesselem, M.; Schoeffel, M.; Maurin, I.; Ramodiharilafy, R.; Autret, G.; Clément, O.; Tharaux, P.-L.;
Boilot, J.-P.; Gacoin, T.; Bouzigues, C.; et al. Multifunctional Rare-Earth Vanadate Nanoparticles: Luminescent
Labels, Oxidant Sensors, and MRI Contrast Agents. ACS Nano 2014, 8, 11126–11137. [CrossRef] [PubMed]
5. Liu, Y.X.; Liu, G.X.; Dong, X.T.; Wang, J.X.; Yu, W.S. Tunable photoluminescence and magnetic properties of
Dy3+ and Eu3+ doped GdVO4 multifunctional phosphors. Phys. Chem. Chem. Phys. 2015, 17, 26638–26644.
[CrossRef] [PubMed]
6. Liu, Y.; Liu, G.; Wang, J.; Dong, X.T.; Yu, W.S. Reddish-orange-emitting and paramagnetic properties of
GdVO4:Sm3+/Eu3+ multifunctional nanomaterials. New J. Chem. 2015, 39, 8282–8290. [CrossRef]
7. Núñez, N.O.; Zambrano, P.; García-Sevillano, J.; Cantelar, E.; Rivera-Fernández, S.; De La Fuente, J.M.;
Ocaña, M. Uniform Poly(acrylic acid)-Functionalized Lanthanide-Doped LaVO4 Nanophosphors with High
Colloidal Stability and Biocompatibility. Eur. J. Inorg. Chem. 2015, 2015, 4546–4554. [CrossRef]
8. Jeyaraman, J.; Shukla, A.; Sivakumar, S. Targeted Stealth Polymer Capsules Encapsulating Ln(3+)-Doped
LaVO4 Nanoparticles for Bioimaging Applications. ACS Biomater. Sci. Eng. 2016, 2, 1330–1340. [CrossRef]
9. Kolesnikov, I.E.; Kalinichev, A.A.; Kurochkin, M.A.; Golyeva, E.V.; Kolesnikov, E.Y.; Kurochkin, A.V.;
Lahderanta, E.; Mikhailov, M.D. YVO4:Nd3+ nanophosphors as NIR-to-NIR thermal sensors in wide
temperature range. Sci. Rep. 2017, 7, 18002. [CrossRef]
10. Spyrogianni, A.; Tiefenboeck, P.; Starsich, F.H.; Keevend, K.; Krumeich, F.; Herrmann, I.K.; Leroux, J.C.;
Sotiriou, G.A. Near-UV Activated, Photostable Nanophosphors for In Vitro Dosimetry and Dynamic
Bioimaging. AICHE J. 2018, 64, 2947–2957. [CrossRef]
11. Gupta, B.K.; Rathee, V.; Narayan, T.N.; Thanikaivelan, P.; Saha, A.; Singh, S.P.; Shanker, V.; Narti, A.A.;
Alayan, P.M. Probing a Bifunctional Luminomagnetic Nanophosphor for Biological Applications: A
Photoluminescence and Time-Resolved Spectroscopic Study. Small 2011, 7, 1767. [CrossRef] [PubMed]
12. Wang, R.; Zhang, F. NIR luminescent nanomaterials for biomedical imaging. J. Mater. Chem. B 2014, 2,
2422–2443. [CrossRef]
13. Lusic, H.; Grinstaff, M.W. X-ray-Computed Tomography Contrast Agents. Chem. Rev. 2013, 113, 1641–1666.
[CrossRef] [PubMed]
14. Chen, C.; Li, C.; Li, T.; Liu, J.; Huang, H.; Bai, T.; Wang, Z.; Shi, Z.; Feng, S. Water-Soluble, Monodisperse,
Lanthanide-Doped Y(Gd)VO4 Nanocrystals as Promising Multimodal Bioprobe. Eur. J. Inorg. Chem. 2015,
2015, 3108–3115. [CrossRef]
Nanomaterials 2020, 10, 149 13 of 13
15. Gnach, A.; Bednarkiewicz, A. Lanthanide-doped up-converting nanoparticles: Merits and challenges. Nano
Today 2012, 7, 532–563. [CrossRef]
16. Duan, X.; Li, Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular
internalization, and trafficking. Small 2013, 9, 1521–1532. [CrossRef] [PubMed]
17. Mosmann, T.J. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and
cytotoxicity assays. J. Immunol. Methods 1993, 65, 55–63. [CrossRef]
18. Shannon, R.D. Revised effective ionic radii and systematic studies of interatomic distances in halides and
chalcogenides. Acta Cryst. A 1976, 32, 751–767. [CrossRef]
19. Matsuura, H.; Miyazawa, T. Infrared spectra and molecular vibrations of ethylene glycol and deuterated
derivatives. Bull. Chem. Soc. Jpn. 1967, 40, 85–94. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
